Elham Askari
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- COVID-19 Clinical Research Studies 5
- Antifungal resistance and susceptibility 5
- SARS-CoV-2 and COVID-19 Research 4
- Oncology 8
- CAR-T cell therapy research 4
- Co-authors
- Brandi Hilder (4 shared papers)Niels W.C.J. van de Donk (4 shared papers)Jesús G. Berdeja (4 shared papers)María‐Victoria Mateos (4 shared papers)Albert Oriol (4 shared papers)Jeffery S. Russell (4 shared papers)Monique C. Minnema (4 shared papers)Amrita Krishnan (4 shared papers)
- Journals
- Blood (3 papers)Scientific Reports (1 paper)Circulation Cardiovascular Imaging (1 paper)Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (1 paper)Climate Risk Management (1 paper)
- Partner nations
- IranSpainNetherlands
In The Last Decade
Elham Askari
25 papers receiving 638 citations
Elham Askari's Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 321
- Oncology 345
- Radiology, Nuclear Medicine and Imaging 163
- Immunology 115
- Infectious Diseases 91
Countries citing papers authored by Elham Askari
This map shows the geographic impact of Elham Askari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Askari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Askari more than expected).
Fields of papers citing papers by Elham Askari
This network shows the impact of papers produced by Elham Askari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Askari. The network helps show where Elham Askari may publish in the future.
Co-authors
The 25 scholars most cited alongside Elham Askari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma Hit paper breakdown → | 2022 | 350 |
| 2 | 2020 | 48 | |
| 3 | 2021 | 40 | |
| 4 | 2021 | 33 | |
| 5 | 2014 | 31 | |
| 6 | 2020 | 30 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 20 | |
| 9 | 2011 | 10 | |
| 10 | 2023 | 9 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2022 | 1 |
About Elham Askari
Elham Askari is a scholar working on Infectious Diseases, Oncology, Radiology, Nuclear Medicine and Imaging, Hematology and Molecular Biology, having authored 29 papers that have together received 651 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), COVID-19 Clinical Research Studies (5 papers), Antifungal resistance and susceptibility (5 papers), CAR-T cell therapy research (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Disaster Management and Resilience (3 papers), Fungal Infections and Studies (3 papers) and Flood Risk Assessment and Management (3 papers). The work is most often cited by research in Hematology (321 citations), Oncology (345 citations), Radiology, Nuclear Medicine and Imaging (163 citations), Immunology (115 citations) and Infectious Diseases (91 citations). Elham Askari has collaborated with scholars based in Iran, Spain and Netherlands. Frequent co-authors include Brandi Hilder, Niels W.C.J. van de Donk, Jesús G. Berdeja, María‐Victoria Mateos, Albert Oriol, Jeffery S. Russell, Monique C. Minnema, Amrita Krishnan, Raluca Verona and Suzette Girgis. Their work appears in journals such as Blood, Scientific Reports, Circulation Cardiovascular Imaging, Oral Surgery Oral Medicine Oral Pathology and Oral Radiology and Climate Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.